|
Ibishev К.S., Naboka Yu. L., Ismailov R. S., Gudima I.A., Prokop Y.O., Vlasenko V.A, Kogan M.I.
Taxonomic characteristics and antibiotic susceptibility of microorganisms verified in the expressed prostate secretion in post-COVID-19 patients with recurrent chronic bacterial prostatitis
|
№6 / 2023
|
|
Pulbere S.A., Kotov S.V., Magomedov M.A., Zheltikova E.A.
Development of purulent-destructive forms of acute pyelonephritis in patients with a history of new coronavirus infection Covid-19
|
№6 / 2023
|
|
А.А. Kamalov, O.Yu. Nesterova, V.Yu. Mareev, Ia.A. Orlova, Yu.V. Mareev, Yu L. Begrambekova, Z.Sh. Pavlova, A.G. Plisyk, L.M. Samokhodskaya, E.A. Mershina, D.A. Ohobotov, A.A. Strigunov, D.D. Tsurskaya
Androgenic status of men with severe COVID-19: the role of testosterone and dihydrotestosterone [within the program FOUNDER (features of a new coronavirus infection course and options therapy depending on the androgenic status)]
|
№3 / 2023
|
|
S.P. Abdullaev, D.V. Vihrev, M.N. Shatokhin, O.V. Teodorovich
The main aspects of the impact of the new coronavirus infection SARS-CoV-2 on the development of infertility in men
|
№5 / 2022
|
|
A.A. Kamalov, O.Yu. Nesterova, Ya.A. Orlova, V.Yu. Mareev, Yu.V. Mareev, Z.Sh. Pavlova, D.A. Okhobotov, A.A. Strigunov, R.P. Vasilevsky, O.M. Nesuk, V.V. Demkin
Protective potential of 5-alpha-reductase inhibitors on Covid19 incidence and severity: results from retrospective cohort study FOUNDER (features of a new coronavirus infection course and options therapy depending on the androgenic status)
|
№5 / 2022
|
|
A.V. Kuzmenko, V.V. Kuzmenko, T.A. Gyaurgiev
Postcovid complications in urology. prevention
|
№3 / 2022
|
|
N.A. Kurashova, B.G. Dashiev, S.I. Kolesnikov, L.I. Kolesnikova
Male reproductive health and COVID-19
|
№2 / 2022
|
|
E.V. Kulchavenya, D.P. Kholtobin, E.V. Telina, A.I. Neymark, P.S. Plugin
Practice of urological departments during the COVID-19 pandemic
|
№1 / 2022
|
|
B.A. Neymark, A.I. Neymark, Ya.V. Yakovets, N.A. Nozdrachev, Kh.S. Ibishev, I.V. Kuzmin
Management of lower urinary tract symptoms in patients with benign prostatic hyperplasia during COVID-19. results of an all-russian observational study “ATLANT”
|
№1 / 2022
|
|
N.D. Akhvlediani, I.A. Reva, A.S. Chernushenko, D.Yu. Pushkar
Andrological aspects of new coronavirus infection Covid-19
|
№6 / 2021
|
|
А.А. Kamalov, V.Yu. Mareev, Ia.A. Orlova, D.A. Ohobotov, Yu.V. Mareev, Yu L. Begrambekova, Z.Sh. Pavlova,
A.G. Plisyk, L.M. Samokhodskaya, E.A. Mershina,
A.A. Tretyakov, O.Yu. Nesterova, A.S. Shurygina
Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity
|
№6 / 2021
|
|
D.V. Perlin, I.V. Alexandrov, A.O. Shmanev,
A.V. Terentiev, A.V. Perlina
Kidney transplantation from Covid-19
positive deceased donor: what are
the consequences for recipients?
|
№4 / 2021
|
Русский
